| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 18,990 | 18,643 | 20,422 | 19,497 | | Cost of Revenue | 5,202 | 5,553 | 6,173 | 7,055 | | | Gross Profit |
-
| 13,090 | 14,249 | 12,442 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 8,112 | 8,303 | 7,361 | 7,522 | | Non Recurring |
-
|
-
|
-
| 49 | | Others | 4,000 | 13,355 | 4,225 | 4,426 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| (8,568) | 2,663 | 444 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 1,676 | (8,568) | 2,663 | 444 | | Interest Expense | 1,144 | 1,147 | 1,227 | 1,380 | | Income Before Tax | 532 | (9,715) | 1,436 | (936) | | Income Tax Expense | 164 | (3,318) | 358 | (266) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 368 | (6,397) | 1,078 | (670) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 368 | (6,397) | 1,078 | (670) | | Preferred Stock And Other Adjustments | (350) | (350) | (315) |
-
| | | Net Income Applicable To Common Shares | $18 | ($6,747) | $763 | ($670) |
|
0.31% Nasdaq 0.00%
Income Statement
